Jointown Pharmaceutical Group boosts subsidiary guarantees to CNY 1,257.64bn

Jointown Pharmaceutical Group Co., Ltd. announced new guarantees totaling 232,469.90 million yuan for 42 subsidiaries as of November 2025. This brings the total outstanding guarantees to 1,257,640.00 million yuan. The guarantees include 161,119.90 million yuan for subsidiaries with a debt-to-asset ratio exceeding 70% and 71,350.00 million yuan for those below 70%. Concurrently, the company released 249,380.00 million yuan in guarantees.

The company's total external guarantees, including those for its controlled subsidiaries, now stand at 2,834,839.62 million yuan, representing 104.06% of its net assets as of December 31, 2024. All guaranteed entities are either wholly-owned or controlled subsidiaries, and their healthy operational status, coupled with centralized financial management, is expected to mitigate risks. No overdue guarantees have been reported.

The guarantees are considered necessary and reasonable, supporting the subsidiaries' business development and operational needs without negatively impacting shareholder interests. Additionally, certain subsidiaries' other shareholders and related parties provided counter-guarantees, primarily through equity pledges.